Skip to main content
OpenTrials

Clinical trial condition

Myelofibrosis

Explore clinical trials studying Myelofibrosis. Study availability and eligibility vary by location and protocol.

175 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Myelofibrosis trial results

Recruiting

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

NCT05980806

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +8 more
Locations
  • City of Hope - Duarte Main Site Duarte, California, United States
  • Maryland Oncology Hematology - Independent of SCRI/ US Oncology Columbia, Maryland, United States
  • Weill Cornell Medicine NewYork-Presbyterian New York, United States
  • Duke University Durham, North Carolina, United States
View all 70 locations
View Trial Details
Recruiting

A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis

NCT05037760

Conditions
Anemia, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Concord Hospital Concord, New South Wales, Australia
  • The Tweed Hospital Tweed Heads, New South Wales, Australia
  • Flinders Medical Centre Woodville South, South Australia, Australia
  • St. Vincents Hospital Melbourne Fitzroy, Victoria, Australia
View all 46 locations
View Trial Details
Recruiting

A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)

NCT06122831

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Guangxi Zhuang Autonomous Region People's Hospital Nanning, Guangxi, China
  • Cangzhou People's Hosipital Cangzhou, Hebei, China
  • Affiliated Hospital of Chengde Medical College Chengde, Hebei, China
View all 22 locations
View Trial Details
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations
  • Massive Bio SYNERGY-AI site Birmingham, Alabama, United States
  • Massive Bio SYNERGY-AI site Mobile, Alabama, United States
  • Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States
  • Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Recruiting

A Study of GLB-001 in Patients With Myeloid Malignancies

NCT06378437

Conditions
Acute Myeloid Leukemia, Blood Coagulation Disorders, Blood Platelet Disorders, +21 more
Locations
  • The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) Hefei, Anhui, China
  • China-Japan Friendship Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • The First Hospital of Hebei Medical Universtiy Shijiazhuang, Hebei, China
View all 14 locations
View Trial Details
Recruiting

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

NCT05423691

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +9 more
Locations
  • UC Davis Health Sacramento, California, United States
  • Columbia University New York, United States
  • Montefiore Einstein Cancer Center The Bronx, New York, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions